Product Information
TAZAROTENE 0.05% GEL is a generic product labeled by Cosette Pharmaceuticals, Inc., priced at $5.3138 per GM under NDC 00713080531. Its NADAC has been published 159 times since Sep 20, 2023.
FDA first approved this application on Sep 13, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Cosette Pharmaceuticals, Inc.NDC
00713080531
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
TAZAROTENEApproval Type
Generic (ANDA)
FDA Application
ANDA215433FDA Approved
9/13/2022
TE Code
AB
On Market Since
9/14/2022
Pharmacological Classes
Price Statistics
The NADAC for TAZAROTENE 0.05% GEL has been published 159 times since Sep 20, 2023, and over the history we have for it it has declined 34.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.3138 per GM |
|---|---|
| All-time high | $8.6540 (Nov 13, 2024) |
| All-time low | $4.6342 (Aug 19, 2026) |
| 52-week high | $7.8139 |
| 52-week low | $4.6342 |
| Median price | $8.1388 |
| Average price | $7.6024 |
| Largest weekly change | +25.9% (May 22, 2024) |
| Weeks tracked | 159 |
| Tracking since | Sep 20, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cosette Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
tazarotene market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Retinoid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TAZAROTENE 0.05% GEL?
The current National Average Drug Acquisition Cost (NADAC) for TAZAROTENE 0.05% GEL, manufactured by Cosette Pharmaceuticals, Inc., is $5.3138 per GM (NDC 00713080531), effective Sep 30, 2026.
How has the price of TAZAROTENE 0.05% GEL changed over time?
Over the history we have for it, the NADAC for TAZAROTENE 0.05% GEL has declined 34.7%. It has been tracked across 159 weekly CMS publications since Sep 20, 2023.
What are the highest and lowest recorded NADAC prices for TAZAROTENE 0.05% GEL?
Since Sep 20, 2023, the NADAC for TAZAROTENE 0.05% GEL has ranged from a low of $4.6342 (Aug 19, 2026) to a high of $8.6540 (Nov 13, 2024), with a median of $8.1388 per GM.
Are there cheaper alternatives to TAZAROTENE 0.05% GEL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TAZAROTENE 0.05% GEL in a comparable dosage form, but none are currently priced below it.
Who manufactures TAZAROTENE 0.05% GEL?
TAZAROTENE 0.05% GEL (NDC 00713080531) is labeled by Cosette Pharmaceuticals, Inc., and CMS classifies it as a generic product.